Laboratory Medicine ›› 2021, Vol. 36 ›› Issue (6): 667-673.DOI: 10.3969/j.issn.1673-8640.2021.06.019
Previous Articles Next Articles
YUE Bo, LI Danjie, TANG Dahai(), LIU Manjiao, HE Jialei, JIANG Mengjie, WEI Xiaoqiang
Received:
2020-07-06
Online:
2021-06-30
Published:
2021-06-30
Contact:
TANG Dahai
CLC Number:
YUE Bo, LI Danjie, TANG Dahai, LIU Manjiao, HE Jialei, JIANG Mengjie, WEI Xiaoqiang. Establishment of a new algorithm for the reference interval of relative change values and application evaluation[J]. Laboratory Medicine, 2021, 36(6): 667-673.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2021.06.019
CV/% | FC | CIλ | RCV | CV/% | FC | CIλ | RCV |
---|---|---|---|---|---|---|---|
0.1 | 0.002 7 | 0.997~1.003 | -0.003~0.003 | 29.1 | 0.945 5 | 0.388~2.574 | -0.612~1.574 |
0.2 | 0.005 5 | 0.995~1.006 | -0.005~0.006 | 29.2 | 0.950 0 | 0.387~2.586 | -0.613~1.586 |
0.3 | 0.008 2 | 0.992~1.008 | -0.008~0.008 | 29.3 | 0.954 4 | 0.385~2.597 | -0.615~1.597 |
0.4 | 0.011 0 | 0.989~1.011 | -0.011~0.011 | 29.4 | 0.958 9 | 0.383~2.609 | -0.617~1.609 |
0.5 | 0.013 7 | 0.986~1.014 | -0.014~0.014 | 29.5 | 0.963 4 | 0.382~2.621 | -0.618~1.621 |
0.6 | 0.016 5 | 0.984~1.017 | -0.016~0.017 | 29.6 | 0.968 0 | 0.380~2.633 | -0.620~1.633 |
0.7 | 0.019 2 | 0.981~1.019 | -0.019~0.019 | 29.7 | 0.972 5 | 0.378~2.645 | -0.622~1.645 |
0.8 | 0.022 0 | 0.978~1.022 | -0.022~0.022 | 29.8 | 0.977 1 | 0.376~2.657 | -0.624~1.657 |
0.9 | 0.024 7 | 0.976~1.025 | -0.024~0.025 | 29.9 | 0.981 6 | 0.375~2.669 | -0.625~1.669 |
1.0 | 0.027 5 | 0.973~1.028 | -0.027~0.028 | 30.0 | 0.986 2 | 0.373~2.681 | -0.627~1.681 |
CV/% | FC | CIλ | RCV | CV/% | FC | CIλ | RCV |
---|---|---|---|---|---|---|---|
0.1 | 0.002 7 | 0.997~1.003 | -0.003~0.003 | 29.1 | 0.945 5 | 0.388~2.574 | -0.612~1.574 |
0.2 | 0.005 5 | 0.995~1.006 | -0.005~0.006 | 29.2 | 0.950 0 | 0.387~2.586 | -0.613~1.586 |
0.3 | 0.008 2 | 0.992~1.008 | -0.008~0.008 | 29.3 | 0.954 4 | 0.385~2.597 | -0.615~1.597 |
0.4 | 0.011 0 | 0.989~1.011 | -0.011~0.011 | 29.4 | 0.958 9 | 0.383~2.609 | -0.617~1.609 |
0.5 | 0.013 7 | 0.986~1.014 | -0.014~0.014 | 29.5 | 0.963 4 | 0.382~2.621 | -0.618~1.621 |
0.6 | 0.016 5 | 0.984~1.017 | -0.016~0.017 | 29.6 | 0.968 0 | 0.380~2.633 | -0.620~1.633 |
0.7 | 0.019 2 | 0.981~1.019 | -0.019~0.019 | 29.7 | 0.972 5 | 0.378~2.645 | -0.622~1.645 |
0.8 | 0.022 0 | 0.978~1.022 | -0.022~0.022 | 29.8 | 0.977 1 | 0.376~2.657 | -0.624~1.657 |
0.9 | 0.024 7 | 0.976~1.025 | -0.024~0.025 | 29.9 | 0.981 6 | 0.375~2.669 | -0.625~1.669 |
1.0 | 0.027 5 | 0.973~1.028 | -0.027~0.028 | 30.0 | 0.986 2 | 0.373~2.681 | -0.627~1.681 |
项目 | CVI | CVA | CVT | 传统算法 | 新算法 | |||
---|---|---|---|---|---|---|---|---|
RCV下限 | RCV上限 | RCV下限 | RCV上限 | |||||
甲胎蛋白 | 12.0 | 4.45 | 12.8 | -35.5 | 35.5 | -30.5 | 43.9 | |
癌胚抗原 | 12.7 | 2.78 | 13.0 | -36.0 | 36.0 | -30.9 | 44.8 | |
糖类抗原125 | 24.7 | 11.67 | 27.3 | -75.7 | 75.7 | -58.0 | 138.3 | |
糖类抗原15-3 | 6.1 | 2.35 | 6.5 | -18.1 | 18.1 | -16.6 | 20.0 | |
糖类抗原19-9 | 16.0 | 6.35 | 17.2 | -47.7 | 47.7 | -39.4 | 65.0 | |
游离前列腺特异性抗原 | 18.1 | 3.12 | 18.4 | -50.9 | 50.9 | -41.6 | 71.3 | |
总前列腺特异性抗原 | 18.1 | 3.13 | 18.4 | -50.9 | 50.9 | -41.6 | 71.3 | |
促甲状腺激素 | 19.3 | 2.79 | 19.5 | -54.1 | 54.1 | -43.8 | 77.9 | |
甲状腺素 | 4.9 | 3.61 | 6.1 | -16.9 | 16.9 | -15.6 | 18.4 | |
三碘甲状腺原氨酸 | 6.9 | 4.23 | 8.1 | -22.4 | 22.4 | -20.3 | 25.4 | |
游离甲状腺素 | 5.7 | 3.73 | 6.8 | -18.9 | 18.9 | -17.3 | 20.9 | |
游离三碘甲状腺原氨酸 | 7.9 | 3.37 | 8.6 | -23.8 | 23.8 | -21.4 | 27.2 |
项目 | CVI | CVA | CVT | 传统算法 | 新算法 | |||
---|---|---|---|---|---|---|---|---|
RCV下限 | RCV上限 | RCV下限 | RCV上限 | |||||
甲胎蛋白 | 12.0 | 4.45 | 12.8 | -35.5 | 35.5 | -30.5 | 43.9 | |
癌胚抗原 | 12.7 | 2.78 | 13.0 | -36.0 | 36.0 | -30.9 | 44.8 | |
糖类抗原125 | 24.7 | 11.67 | 27.3 | -75.7 | 75.7 | -58.0 | 138.3 | |
糖类抗原15-3 | 6.1 | 2.35 | 6.5 | -18.1 | 18.1 | -16.6 | 20.0 | |
糖类抗原19-9 | 16.0 | 6.35 | 17.2 | -47.7 | 47.7 | -39.4 | 65.0 | |
游离前列腺特异性抗原 | 18.1 | 3.12 | 18.4 | -50.9 | 50.9 | -41.6 | 71.3 | |
总前列腺特异性抗原 | 18.1 | 3.13 | 18.4 | -50.9 | 50.9 | -41.6 | 71.3 | |
促甲状腺激素 | 19.3 | 2.79 | 19.5 | -54.1 | 54.1 | -43.8 | 77.9 | |
甲状腺素 | 4.9 | 3.61 | 6.1 | -16.9 | 16.9 | -15.6 | 18.4 | |
三碘甲状腺原氨酸 | 6.9 | 4.23 | 8.1 | -22.4 | 22.4 | -20.3 | 25.4 | |
游离甲状腺素 | 5.7 | 3.73 | 6.8 | -18.9 | 18.9 | -17.3 | 20.9 | |
游离三碘甲状腺原氨酸 | 7.9 | 3.37 | 8.6 | -23.8 | 23.8 | -21.4 | 27.2 |
[1] |
HARRIS E K, YASAKA T. On the calculation of a "reference change" for comparing two consecutive measurements[J]. Clin Chem, 1983,29(1):25-30.
DOI URL |
[2] |
FRASER C G, STEVENSON H P, KENNEDY IAN M G. Biological variation data are necessary prerequisites for Objective autoverification of clinical laboratory data[J]. Accreditation and Quality Assurance, 2002,7(11):455-460.
DOI URL |
[3] | PINEDA-TENOR D, LASERNA-MENDIETA E J, TIMÓN-ZAPATA J, et al. Biological variation and reference change values of common clinical chemistry and haematologic laboratory analytes in the elderly population[J]. Clin Chem Lab Med, 2013,51(4):851-862. |
[4] |
TÄGER T, SCHELL M, CEBOLA R, et al. Biological variation,reference change value(RCV) and minimal important difference(MID) of inspiratory muscle strength(PImax) in patients with stable chronic heart failure[J]. Clin Res Cardiol, 2015,104(10):822-830.
DOI URL |
[5] |
FRASER C G, HARRIS E K. Generation and application of data on biological variation in clinical chemistry[J]. Crit Rev Clin Lab Sci, 1989,27(5):409-437.
DOI URL |
[6] | 郭玮, 宋斌斌, 沈隽霏, 等. 基于实验室数据信息库建立丙氨酸转氨酶生物参考区间[J]. 中华医学杂志, 2015,95(32):2599-2602. |
[7] |
WALZ B, FIERZ W. The concept of reference change values(RCV). Will it supersede reference intervals?[J]. Ther Umsch, 2015,72(2):130-135.
DOI URL |
[8] |
RØRAAS T, STØVE B, PETERSEN P H, et al. Biological variation:the effect of different distributions on estimated within-person variation and reference change values[J]. Clin Chem, 2016,62(5):725-736.
DOI URL |
[9] | PLEBANI M, LIPPI G. Biological variation and reference change values:an essential piece of the puzzle of laboratory testing[J]. Clin Chem Lab Med, 2012,50(2):189-190. |
[10] |
FRANKENSTEIN L, WU A H, HALLERMAYER K, et al. Biological variation and reference change value of high-sensitivity troponin T in healthy individuals during short and intermediate follow-up periods[J]. Clin Chem, 2011,57(7):1068-1071.
DOI URL |
[11] |
KAWANO R, ICHIHARA K, WADA T. Derivation of level-specific reference change values(RCV) from a health screening database and optimization of their thresholds based on clinical utility[J]. Clin Chem Lab Med, 2016,54(9):1517-1529.
DOI URL |
[12] |
FOKKEMA M R, HERRMANN Z, MUSKIET F A, et al. Reference change values for brain natriuretic peptides revisited[J]. Clin Chem, 2006,52(8):1602-1603.
DOI URL |
[13] | 岳波, 刘曼娇, 唐大海, 等. 血细胞参数个性化参考区间的建立及验证[J]. 临床检验杂志, 2017,35(2):107-110. |
[14] | 岳波, 刘曼娇, 唐大海, 等. 常规体检生物化学项目波动性参考区间的建立与验证[J]. 临床检验杂志, 2018,36(6):418-421. |
[15] |
JONES G R D. Estimates of within-subject biological variation derived from pathology databases:an approach to allow assessment of the effects of age,sex,time between sample collections,and analyte concentration on reference change values[J]. Clin Chem, 2019,65(4):579-588.
DOI URL |
[16] | 张利, 何瑶. 肿瘤标志物的参考变化值和参考变化因子比较[J]. 检验医学, 2019,34(11):991-993. |
[17] | 李小玲, 张玫, 黄亨建. 甲状腺功能检测参考变化值及质量规范的应用[J]. 国际检验医学杂志, 2015,36(4):506-507. |
[18] | Clinical and Laboratory Standards Institute. Defining,establishing,and verifying reference intervals in the clinical laboratory[S]. EP28-A3c,CLSI, 2010 . |
[19] | 陈红燕, 裘海文. 检验结果参考变化值建立的探讨[J]. 检验医学, 2015,30(5):529-532. |
[20] | 陈政君, 张晨, 宋斌斌, 等. 常规生化检验项目生物学变异的研究[J]. 中华检验医学杂志, 2012,35(10):926-931. |
[1] | AN Yinghong, YAO Kechun, SU Chengming, TANG Jinhua, YANG Lixin, GAO Jie, XU Yanting, YAN Qiuhong, ZHAN Hongyan, MA Yueyun. Survey of serum homocysteine levels of apparently healthy subjects in Beijing [J]. Laboratory Medicine, 2023, 38(11): 1036-1040. |
[2] | ZHAO Yanhong, FU Lin, LIU Biao, XIAO Meifang. Reference interval of lactate dehydrogenase among 3-14-year-old population in Hainan [J]. Laboratory Medicine, 2023, 38(11): 1041-1043. |
[3] | XU Qianqian, JIANG Wangqing, SHEN Linjie, LU Yingjie, CHEN Jian, JIANG Haoqin. Establishment of the reference intervals for related parameters of adult reticulocytes in Shanghai [J]. Laboratory Medicine, 2022, 37(7): 641-645. |
[4] | MIAO Linzi, LU Yao, QU Chenxue, YOU Ran, GONG Yan. Establishment of the reference intervals of leukocyte surface CD64 and HLA-DR indexes for healthy adults and related factors [J]. Laboratory Medicine, 2022, 37(3): 240-245. |
[5] | LU Youli, YANG Shuangshuang, ZHANG Meiwei, OU Meixian, DONG Chunxia, SHEN Weiwei, JIANG Fengli, LI Shuijun. Simultaneous determination of 5 steroid hormones in human serum by ultra-performance liquid chromatography-tandem mass spectrometry and establishment of reference intervals in healthy adults [J]. Laboratory Medicine, 2022, 37(2): 165-173. |
[6] | YU Jianhong, PENG Qingyuan, YIN Minggang. Establishment of reference intervals of serum PGⅠ,PGⅡ and PGR for apparently healthy subjects in Zigong [J]. Laboratory Medicine, 2022, 37(1): 23-27. |
[7] | LI Jing, QUAN Hui, ZENG Zhirong, WEI Yi. Establishment of the reference interval of small and dense low-density lipoprotein cholesterol in apparently healthy adults in Chengdu [J]. Laboratory Medicine, 2021, 36(6): 609-614. |
[8] | WANG Zipeng, OUYANG Changli, GENG Deqin, WANG Dunjing. Establishment of cerebrospinal fluid IL-6 reference interval in non-inflammatory central nervous system diseases [J]. Laboratory Medicine, 2021, 36(6): 627-630. |
[9] | JI Zhi, DENG Lingyan, LI Jiaoyuan, WANG Xu, LI Huijun, CHENG Liming. Reference interval establishment of serum cytokeratin 19 fragment for healthy adults in Wuhan [J]. Laboratory Medicine, 2021, 36(5): 490-494. |
[10] | ZOU Ning, CHEN Guangxi, MA Hua, Qiurang, Zhaxinamo. Survey on the reference intervals of venous blood cells among native Tibetan adults in Aba county [J]. Laboratory Medicine, 2021, 36(2): 198-201. |
[11] | AN Chongwen, LI Haixia, JIAO Lili. Establishment of reference interval for the detection of serum protein electrophoresis by V8 Nexus high speed automated capillary electrophoresis apparatus [J]. Laboratory Medicine, 2021, 36(1): 8-12. |
[12] | YUE Chaoyan, DUAN Chaohui, ZHANG Di, WEI Jie, LUO Xiaohong, ZHANG Qianlan, WU Yong, YING Chunmei. Performance evaluation of acridinium ester labeled direct chemiluminescence method for the detection of AMH and establishment of adult female AMH reference interval [J]. Laboratory Medicine, 2021, 36(1): 95-100. |
[13] | WU Qun, SHEN Junfei, WU Wenhao, WANG Beili, PAN Baishen, GUO Wei. Establishment of reference intervals of total bilirubin and direct bilirubin by indirect method [J]. Laboratory Medicine, 2020, 35(8): 749-752. |
[14] | DU Yuxuan, WANG Wei, HE Falin, ZHONG Kun, YUAN Shuai, LIU Jiali, ZHANG Zhixin, WANG Zhiguo. Investigation and analysis on pediatric reference intervals of routine chemistry items in China [J]. Laboratory Medicine, 2020, 35(7): 676-681. |
[15] | ZHANG Li, GE Liang, ZHANG Lanfang, MA Xiaoli, SUN Linchun. Establishment of reference interval of human leukocyte antigen-B27 in apparent healthy children [J]. Laboratory Medicine, 2020, 35(7): 695-698. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||